| 2008
U.S. Breast Cancer Fact Sheet
- Breast
cancer is the most frequently diagnosed cancer among women.
- An estimated
178,480 new cases of invasive breast cancer are expected to
occur among women in the
United States during 2007.
- In addition
to invasive breast cancer, 62,030 new cases of in situ breast
cancer are expected to occur
among women during 2007. Ductal carcinoma in situ (DCIS) accounted
for 85 percent of these in situ
breast cancers.
- An estimated
2,030 new cases of breast cancer will be diagnosed in men in
2007.
- Breast
cancer is second only to lung cancer in cancer deaths among
women.
- An estimated
40,460 women will die from breast cancer in 2007.
- An estimated
450 men will die from breast cancer in 2007.
- Breast
cancer death rate has been dropping about 2 percent annually
since 1990 to 2002 in all women
combined, with larger decreases in younger (<50 years) women,
a decline attributed to earlier detection
through screening, increased awareness, and improved treatment.
Cancer Facts & Figures 2008, ACS
- One woman
is diagnosed with breast cancer every three minutes, and one
woman will die of breast cancer every 13 minutes in the United
States.
- The relative
survival rates for women diagnosed with breast cancer are:
- 88
percent at 5 years after diagnosis
- 80
percent after 10 years
- 71
percent after 15 years
- 63
percent after 20 years
- The five
year relative survival rate for women with localized breast
cancer (cancer that has not spread to
lymph nodes or other locations outside the breast) has increased
from 80 percent in the 1950s to over 95
percent (98 percent) in 2007.
- The five
year survival rate for regional disease is 83 percent and 26
percent for distantstage
disease.
- The relative
survival rates for women diagnosed with breast cancer before
age 40 are slightly lower.
- 82
percent for women younger then 40
- 89
percent for women aged 4074
- 88
percent for women aged 75 and older
- African
American women are less likely to survive five years than white
women, 76 percent vs. 90 percent respectively.
- The most
proven and significant risk factors for getting breast cancer
are being female and getting older.
Susan G. Komen for the Cure Brand Central Guidelines Page 1
of 2--Printed: 02 May 2007
- Approximately
five to ten percent of breast cancers are due to heredity. The
majority of women with breast cancer have no known significant
family history or other known risk factors.
- A woman’s
chance of developing breast cancer increases with age. In the
United States, a woman has
about a 13.2 percent, or 1 in 8, lifetime risk of developing
breast cancer.
- Incidence
trends of breast cancer for all races are as follows:
- 1975-1980:
Incidence was essentially constant
- 1980-1987:
Incidence increased by almost 4 percent per year
- 1987-2002:
Incidence rates increased by 0.3 percent per year
- For the
period 1998-2002, women ages 20-24 have the lowest incidence
rate (1.3 cases per 100,000
population); women ages 75-79 have the highest incidence rate
(496.6 cases per 100,000).
- During
1998-2002, the median age at the time of breast cancer diagnosis
was 61 years old.
- From 1980-1987,
incidence rates of invasive breast cancer increased among women
aged 40-49
and 50 and older (3.5 percent and 4.2 percent per year respectively).
Since then, breast cancer incidence rates have increased among
women aged 50 and older, though at a slower rate. Incidence
rates have declined slightly among women aged 40-49 and little
change among women younger then 40.
- Rapid
incidence increase between 1980 and 1987 is due largely to greater
use of mammography
screening and increased detection of breast cancers.
- During
1980-1987,
incidence rates of smaller tumors ≤ 2.0 cm more than doubled.
Rates of larger tumors
(3.0 cm or more) decreased 27 percent.
- During
1988-1999, the trend in diagnosis of smaller tumors ≤
2.0 cm increased by 2.1 percent per year
and has stabilized since.
- During
1992-2000, African American women were less likely to be diagnosed
with smaller tumors (≤ 2.0 cm) and more likely to be diagnosed
with larger tumors (2.15.0 and >5.0 cm) than white women.
- White
women have a higher incidence of breast cancer than African
American women after age 35.
However, African American women have a slightly higher incidence
rate before age 35 and are more likely to die from breast cancer
at every age.
- During
1992-2002, overall incidence rates increased in Asian Americans
and Pacific Islanders (1.5 percent per year), decreased in American
Indian/Alaska Natives (3.5 percent per year) and did not change
significantly for Caucasians, African Americans or Hispanics/Latinas.
- Mortality
trends of breast cancer for all races are as follows:
- 1975-1990:
Mortality rate increased by 0.4 percent per year
- 1990-2002:
Mortality rate decreased by 2.3 percent per year
- From 1990-2002,
death rates decreased by 3.3 percent per year among women younger
than 50 and by
2.0 percent per year among women 50 and older.
- From 1990-2002,
breast cancer death rates declined by 2.4 percent per year in
whites, 1.8 percent in
Hispanics/Latinas, 1.0 percent ion African Americans and Asian
Americans and Pacific Islanders and did
not decline in American Indian/Alaska Natives.
- African
Americans have the highest death rate from breast cancer of
any racial/ethnic group in the United
States.
- Since
2002, death rates have been 37 percent higher in African Americans
than in white women.
- The chance
of a woman dying from breast cancer is about 1 in 33 (3 percent).
- Ninety-five
percent of new cases and 98 percent of breast cancer deaths
reported during 1996-2002
occurred in women ages 40 and older.
Breast Cancer Facts and Figures 2005-2006, ACS
- In the
United States today, there are more than two million breast
cancer survivors.
Data source: 2004 Submission. U.S. Prevalence counts were estimated
by applying U.S. populations to SEER-9 Limited Duration Prevalence
proportions. Populations from January 2002 were based on the
average of the July 2001 and July 2002 population estimates
from the U.S. Bureau of Census. See graphical data here. National
Cancer Institute. American Cancer Society, Surveillance Research,
2004.
|